Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.48 |
| ▸ | ORAI2 | Q96SN7 | 2/20 | 0.48 |
| ▸ | ORAI3 | Q9BRQ5 | 2/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.46 |
| ▸ | LIPE | Q05469 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.42 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL910658 | 0.83 | ENPP2 (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL9131 | 0.81 | TSHR (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL29418123 | 0.81 | ALDH1A1 (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL165536 | 0.81 | ALDH1A1 (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL29392408 | 0.81 | TSHR (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL28083714 | 0.81 | TSHR (0.50) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL1580839 | 0.78 | ENPP2 (0.46) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL150114 | 0.78 | ENPP2 (0.46) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL56105 | 0.78 | CYP3A4 (0.47) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL115327 | 0.78 | ENPP2 (0.46) | ENPP2CA4CA6CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027085-A1 | EYE CARE COMPOSITION CONTAINING L-ERGOTHIONEINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | GENE III BIOTECHNOLOGY CO., LTD. (CN) | 2026-01-29 | — | — | US | claimed |
| CN-118702890-A | High-damping bio-based polyurethane composite material capable of self-repairing at room temperature and preparation method thereof | 广东工业大学 | 2024-09-27 | — | — | CN | claimed |
| CN-113980056-B | Boron bismuth element-based thermal activation delay fluorescent material, preparation method thereof and organic light-emitting diode | 北京大学深圳研究生院 | 2024-06-07 | — | — | CN | claimed |
| US-11773209-B2 | Quinone-containing poly(arylene), methods for the manufacture thereof, and use for electrochemical gas separation | VERDOX, INC (US) | 2023-10-03 | — | — | US | claimed |
| EP-4244270-A1 | QUINONE-CONTAINING POLY(ARYLENE), METHODS FOR THE MANUFACTURE THEREOF, AND USE FOR ELECTROCHEMICAL GAS SEPARATION | Verdox, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| CN-116396463-A | High-toughness crosslinked polyurethane capable of being reprocessed at room temperature and preparation method thereof | 四川大学 | 2023-07-07 | — | — | CN | claimed |
| CN-112850685-B | Two-dimensional carbon material and preparation method and application thereof | 厦门稀土材料研究所 | 2022-10-18 | — | — | CN | claimed |
| WO-2022103474-A1 | QUINONE-CONTAINING POLY(ARYLENE), METHODS FOR THE MANUFACTURE THEREOF, AND USE FOR ELECTROCHEMICAL GAS SEPARATION | VERDOX, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-20220145002-A1 | QUINONE-CONTAINING POLY(ARYLENE), METHODS FOR THE MANUFACTURE THEREOF, AND USE FOR ELECTROCHEMICAL GAS SEPARATION | US DEPARTMENT OF ENERGY | 2022-05-12 | — | — | US | claimed |
| US-8137822-B2 | Synthesis of phenyl-substituted polyfluoroanthenes and the use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2012-03-20 | — | — | US | claimed |
| EP-1877518-B1 | SYNTHESIS OF PHENYL-SUBSTITUTED POLYFLUOROANTHENES AND THE USE THEREOF | BASF SE (DE) | 2010-02-24 | — | — | EP | claimed |
| US-20080213623-A1 | 7,10-bis(acryloyl, styryl, or glycidyl-substituted phenyl)fluoranthene polymerized in the presence of a nickel or palladium catalyst; photopolymerized after applied to film substrate for organic light-emitting diodes; improved stability, high efficiency and quantum yield, emission maximum in blue region | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | claimed |
| US-20070287821-A1 | Synthesis of Polynaphthalenes and Their Use | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-13 | — | — | US | claimed |
| EP-1799677-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | Ranbaxy Laboratories Limited (IN) | 2007-06-27 | — | — | EP | claimed |
| WO-2006038100-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-13 | — | — | WO | claimed |
| US-6630577-B2 | Useful for producing bioconjugates | PROLINX, INC. | 2003-10-07 | — | — | US | claimed |
| EP-1264833-A2 | 1,2-Phenylenediboronic acid reagents and complexes | PROLINX, INC. (US) | 2002-12-11 | — | — | EP | claimed |
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | PROLINX, INC. | 2002-03-28 | — | — | US | claimed |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2026-05-26 | — | — | US | disclosed |
| US-4565883-A | Cyanoacrylate adhesive composition | TEROSON GMBH (DE) | 1986-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027085-A1 | EYE CARE COMPOSITION CONTAINING L-ERGOTHIONEINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | TTPA, HSF1, KEAP1 | ENPP2 3057/4885CA4 3689/4885CA6 2608/4885 |
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | BCR, MGST1, SULT1E1 | ENPP2 3879/4885CA4 1156/4885CA6 375/4885 |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | GRM3, GRM2, GRM1 | ENPP2 1668/4885CA4 2801/4885CA6 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.